Portable blood gas analyzers are
intended for use in testing at patient bedside. Portable POC blood gas
analyzers are easy to transport and are most cost effective in units with a low
test volume per day. Portable analyzers require the least maintenance compared
to other types.
EME
Blood Gas and Electrolyte Analyzers Market is estimated to account for US$
139.4 Mn in terms of value in 2020 and is expected to reach US$ 195.7 Mn in terms
of value by the end of 2027.
EME Blood Gas and Electrolyte
Analyzers Market: Drivers
Approval and launch of new
devices is expected to propel growth of EME blood gas and electrolyte analyzers
market over the forecast period. For instance, in March 2020, Siemens
Healthineers received the U.S. Food and Drug Administration clearance for its
RapidPoint 500e blood gas analyzer for diagnosing and monitoring people in the
intensive care unit, operating room or emergency room.
EME Blood Gas and Electrolyte Analyzers
Market: Opportunities
Launch of digital solutions is
expected to offer lucrative growth opportunities for players in EME blood gas
and electrolyte analyzers market. For instance, in May 2020, F. Hoffmann-La
Roche Ltd. launched Roche v-TAC, a digital diagnostic solution that allows
clinicians to obtain results for arterial blood gas values from patients with
respiratory or metabolic abnormalities.
EME Blood Gas and Electrolyte
Analyzers Market: Restraints
Product recall is expected to
hinder the market growth. For instance, in August 2019, Radiometer America Inc.
recalled ABL90 FLEX Analyzer, owing to software security vulnerabilities.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3971
Key Takeaways:
EME blood gas and electrolyte
analyzers market was valued at US$ 133.2 Mn in 2019 and is forecast to reach a
value of US$ 195.7 Mn by 2027 at a CAGR of 5.0% between 2020 and 2027. Major
factor driving the growth of EME blood gas and electrolyte analyzers market
during the forecast period include increasing prevalence of chronic disorders,
and product launches.
Laboratory analyzers held
dominant position in EME blood gas and electrolyte analyzers market in 2019,
accounting for 38.1% share in terms of value, followed by benchtop analyzers
and portable analyzers, respectively. Centralized laboratories utilize blood
gas and electrolyte analyzers on a large basis. Since, point of care testing is
not highly used in these regions, laboratory analyzers are expected to witness
growth over the forecast period.
Market Trends
Major players in the market are
focused on approval and launch of new products to expand their product
portfolio. For instance, in May 2020, Abbott Laboratories received Emergency
Use Authorization from the US Food and Drug Administration (FDA) for the company's
molecular test for COVID-19 for use on its new Alinity m molecular laboratory
instrument.
Major players in the market are
also focused on adopting partnership strategies to enhance their market share.
For instance, in May 2020, EKF Diagnostics signed a three-year distribution
agreement with Tosoh Europe N.V. for the distribution of its Quo-Test HbA1c
point-of-care analyzer in the Middle East and Africa.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/eme-blood-gas-and-electrolyte-analyzers-market-3971
Regulations
Middle East
There are two government bodies,
SGK and MOh, in Turkey which are involved in reimbursing healthcare expenses
incurred by healthcare institutions such as hospitals. SGK reimburses expenses
suffered by using the treatment type and medical device listed in the
Healthcare Implementation Communique (SUT).
National legislation regarding
medical device regulation in Turkey has been aligned with that of the EU.
EME Blood Gas and Electrolyte
Analyzers Market: Competitive Landscape
Major players operating in EME
blood gas and electrolyte analyzers market include, Abbott Laboratories, Medica
Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche
Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics
Mannheim GmbH, and Instrumentation Laboratories (Werfen).
EME Blood Gas and Electrolyte Analyzers
Market: Key Developments
April 2020: DiaSorin Inc.
completed studies to support the launch of a new serological and
high-processing volume test for detecting the presence of antibodies in patients
infected with the SARS-CoV-2.
January 2020: Abbott Laboratories
warned customers to discontinue use of its i-Stat Blue Chem8+ and CG4+ blood
analysis cartridges
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3971
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment